View Author
scopus: 16937786600

Vandenbroucke, J.P.

( J.P. Vandenbroucke)


patient dopamine hyperprolactinemia agonist dopamine agonists prevalence incidence prolactinoma dopamine agonist-treated hyperprolactinemia incidence rate dopamine agonist women diagnosis treatment pharmacy disease agonist-treated prescription subject endocrinol database netherland prolactin number study idiopathic hyperprolactinemia definition dopamine agonist users metab definition b parkinson incidence rates pharmacy records hyperprolactinemic patients dopamine agonisttreated hyperprolactinemia record dopamine agonist use proportion lactation cabergoline person-year pharmo network pivonello r idiopathic dopamine agonist therapy dopamine agonist treatment source population cohort tumor laboratory result withdrawal index date pharmo pharmaco-epidemiological database center hyperprolactinemic medication verification value population symptom adenomas network calendar bromocriptine therapy analysis majority –2734 colao di sarno physician leiden prolactin levels lactation withdrawal laboratory results hospital discharge codes prevalence proportions incident




2 Most Recent Publications

Estimated age- and sex-specific incidence and prevalence of dopamine agonist-treated hyperprolactinemia (Article)
Kars, M. Souverein, P. Herings, R.M.C. Romijn, J.A. Vandenbroucke, J.P. Boer, A. de Dekkers, O.M.
2009-08-01
Oral contraceptives and rheumatoid arthritis : further epidemiologic evidence for a protective effect (Doctoral Thesis)
Vandenbroucke, J.P.
1983-03-30